제약용 RFID 시장 분석 및 예측(-2035년) : 종류별, 제품별, 서비스별, 기술별, 구성요소별, 용도별, 프로세스별, 전개 방식별, 최종사용자별, 기능별

The global RFID in Pharmaceuticals Market is projected to grow from $4.3 billion in 2025 to $7.8 billion by 2035, at a compound annual growth rate (CAGR) of 6.2%. Growth is driven by increasing regulatory requirements for drug traceability, technological advancements in RFID solutions, and rising demand for efficient supply chain management in the pharmaceutical industry. The RFID in Pharmaceuticals Market is characterized by a moderately consolidated structure, with the top segments being asset tracking and inventory management, each holding approximately 30% of the market share. Other key applications include patient safety and authentication, which collectively account for around 40%. The market is driven by the need for enhanced supply chain visibility and compliance with stringent regulatory requirements. In terms of volume, the market sees significant installations across pharmaceutical manufacturing and distribution facilities, with millions of RFID tags deployed annually.

The competitive landscape features a mix of global and regional players, with major companies like Zebra Technologies, Avery Dennison, and Impinj leading the market. The degree of innovation is high, with companies investing in advanced RFID technologies and integrated solutions. Mergers and acquisitions, as well as strategic partnerships, are common as firms aim to expand their technological capabilities and geographic reach. The market is witnessing increased collaboration between RFID technology providers and pharmaceutical companies to develop customized solutions that address specific industry challenges.

The RFID in Pharmaceuticals market is segmented by Type, with passive RFID tags dominating due to their cost-effectiveness and wide applicability in inventory management and supply chain tracking. Active RFID tags, while more expensive, are gaining traction for their ability to provide real-time data and enhanced tracking capabilities, particularly in high-value drug monitoring. The demand is driven by the need for efficient inventory management and regulatory compliance, with passive tags being preferred for their lower cost and ease of deployment.

In terms of Technology, the market is primarily driven by UHF (Ultra-High Frequency) RFID systems, which offer longer read ranges and faster data transfer rates, making them ideal for large-scale pharmaceutical operations. HF (High Frequency) RFID systems are also significant, especially in applications requiring close-range scanning, such as patient tracking and drug authentication. The growth in UHF technology is propelled by advancements in RFID infrastructure and the increasing need for efficient supply chain management.

The Application segment sees the highest demand in drug tracking and inventory management, where RFID technology ensures accurate tracking of pharmaceuticals throughout the supply chain, reducing errors and preventing counterfeiting. Patient safety and compliance monitoring are also critical applications, as RFID helps in ensuring the correct administration of medications. The growing emphasis on reducing drug counterfeiting and enhancing patient safety drives the adoption of RFID in these applications.

End User segmentation highlights pharmaceutical manufacturers as the primary users of RFID technology, leveraging it to enhance supply chain efficiency and regulatory compliance. Hospitals and healthcare providers are increasingly adopting RFID to improve patient safety and operational efficiency. The trend towards digital transformation in healthcare and the need for real-time data access are significant factors driving RFID adoption among these end users.

The Component segment is dominated by RFID tags, which are essential for tracking and data collection in pharmaceutical applications. RFID readers and middleware are also crucial, facilitating data capture and integration into existing IT systems. The increasing complexity of pharmaceutical supply chains and the need for seamless data flow are driving investments in advanced RFID components, with a focus on improving accuracy and reliability in data management.

Geographical Overview

North America: The RFID in Pharmaceuticals market in North America is highly mature, driven by stringent regulatory requirements and advanced healthcare infrastructure. The United States is the key player, with significant demand from pharmaceutical manufacturing and distribution sectors. Canada also contributes to market growth with its focus on healthcare innovation and technology adoption.

Europe: Europe exhibits moderate market maturity, with increasing adoption of RFID technology to enhance supply chain efficiency and comply with regulatory mandates. Germany and the United Kingdom are notable countries, leveraging RFID to improve pharmaceutical logistics and patient safety.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in the RFID in Pharmaceuticals market, driven by expanding pharmaceutical industries and rising healthcare investments. China and India are leading the charge, focusing on technological advancements and improving drug traceability to combat counterfeiting.

Latin America: The market in Latin America is in the early stages of development, with growing awareness of RFID benefits in pharmaceuticals. Brazil and Mexico are key countries, where government initiatives and increasing pharmaceutical exports are driving demand for RFID solutions.

Middle East & Africa: The RFID in Pharmaceuticals market in the Middle East & Africa is nascent, with gradual adoption influenced by the need for improved healthcare logistics. The United Arab Emirates and South Africa are notable countries, investing in healthcare infrastructure and technology to enhance pharmaceutical supply chain management.

Key Trends and Drivers

Enhanced Supply Chain Visibility

The integration of RFID technology in the pharmaceutical sector is significantly enhancing supply chain visibility. By providing real-time tracking of pharmaceutical products, RFID tags help in reducing the risk of counterfeit drugs, ensuring authenticity, and improving inventory management. This trend is driven by the need for stringent regulatory compliance and the demand for efficient supply chain operations. As a result, pharmaceutical companies are increasingly adopting RFID solutions to streamline operations and ensure product safety.

Regulatory Compliance and Safety

Regulatory bodies worldwide are mandating the use of RFID technology to enhance drug safety and traceability. With increasing concerns over drug counterfeiting and patient safety, regulations such as the Drug Supply Chain Security Act (DSCSA) in the United States are pushing pharmaceutical companies to implement RFID solutions. These regulations are driving the adoption of RFID technology as it provides a reliable method for tracking and authenticating pharmaceuticals throughout the supply chain.

Technological Advancements in RFID Solutions

Advancements in RFID technology, including the development of more cost-effective and efficient RFID tags, are propelling the growth of the RFID in pharmaceuticals market. Innovations such as improved read range, data storage capabilities, and integration with IoT platforms are enhancing the functionality of RFID systems. These technological improvements are making RFID solutions more accessible and appealing to pharmaceutical companies looking to optimize their operations and ensure compliance.

Increased Adoption of IoT and Automation

The convergence of RFID technology with IoT and automation is transforming the pharmaceutical industry. By integrating RFID with IoT platforms, companies can achieve greater automation in tracking and managing pharmaceutical products. This integration facilitates real-time data collection and analysis, enabling better decision-making and operational efficiency. The push towards digital transformation and smart manufacturing is further accelerating the adoption of RFID in the pharmaceutical sector.

Focus on Patient Safety and Quality Assurance

Patient safety and quality assurance are paramount in the pharmaceutical industry, and RFID technology is playing a crucial role in achieving these objectives. By providing accurate and real-time data on drug expiration, storage conditions, and handling, RFID ensures that pharmaceuticals are safe for consumption. This focus on patient safety is driving pharmaceutical companies to invest in RFID solutions that enhance quality control processes and reduce the risk of errors in drug dispensing and administration.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Process
• 2.9 Key Market Highlights by Deployment
• 2.10 Key Market Highlights by Functionality

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Active RFID
  • 4.1.2 Passive RFID
  • 4.1.3 Semi-passive RFID
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Tags
  • 4.2.2 Readers
  • 4.2.3 Software
  • 4.2.4 Printers
  • 4.2.5 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Consulting
  • 4.3.2 Integration
  • 4.3.3 Maintenance
  • 4.3.4 Managed Services
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Ultra-High Frequency (UHF)
  • 4.4.2 High Frequency (HF)
  • 4.4.3 Low Frequency (LF)
  • 4.4.4 Near Field Communication (NFC)
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Microchip
  • 4.5.2 Antenna
  • 4.5.3 Substrate
  • 4.5.4 Encapsulation
  • 4.5.5 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Drug Serialization
  • 4.6.2 Inventory Management
  • 4.6.3 Supply Chain Management
  • 4.6.4 Anti-counterfeiting
  • 4.6.5 Clinical Trials
  • 4.6.6 Cold Chain Monitoring
  • 4.6.7 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Pharmaceutical Manufacturers
  • 4.7.2 Healthcare Providers
  • 4.7.3 Logistics and Transportation
  • 4.7.4 Retail Pharmacies
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Process (2020-2035)
  • 4.8.1 Manufacturing
  • 4.8.2 Packaging
  • 4.8.3 Distribution
  • 4.8.4 Dispensing
  • 4.8.5 Others
• 4.9 Market Size & Forecast by Deployment (2020-2035)
  • 4.9.1 On-Premise
  • 4.9.2 Cloud-Based
  • 4.9.3 Hybrid
  • 4.9.4 Others
• 4.10 Market Size & Forecast by Functionality (2020-2035)
  • 4.10.1 Tracking
  • 4.10.2 Tracing
  • 4.10.3 Authentication
  • 4.10.4 Data Logging
  • 4.10.5 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Process
    • 5.2.1.9 Deployment
    • 5.2.1.10 Functionality
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Process
    • 5.2.2.9 Deployment
    • 5.2.2.10 Functionality
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Process
    • 5.2.3.9 Deployment
    • 5.2.3.10 Functionality
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Process
    • 5.3.1.9 Deployment
    • 5.3.1.10 Functionality
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Process
    • 5.3.2.9 Deployment
    • 5.3.2.10 Functionality
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Process
    • 5.3.3.9 Deployment
    • 5.3.3.10 Functionality
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Process
    • 5.4.1.9 Deployment
    • 5.4.1.10 Functionality
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Process
    • 5.4.2.9 Deployment
    • 5.4.2.10 Functionality
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Process
    • 5.4.3.9 Deployment
    • 5.4.3.10 Functionality
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Process
    • 5.4.4.9 Deployment
    • 5.4.4.10 Functionality
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Process
    • 5.4.5.9 Deployment
    • 5.4.5.10 Functionality
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Process
    • 5.4.6.9 Deployment
    • 5.4.6.10 Functionality
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Process
    • 5.4.7.9 Deployment
    • 5.4.7.10 Functionality
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Process
    • 5.5.1.9 Deployment
    • 5.5.1.10 Functionality
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Process
    • 5.5.2.9 Deployment
    • 5.5.2.10 Functionality
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Process
    • 5.5.3.9 Deployment
    • 5.5.3.10 Functionality
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Process
    • 5.5.4.9 Deployment
    • 5.5.4.10 Functionality
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Process
    • 5.5.5.9 Deployment
    • 5.5.5.10 Functionality
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Process
    • 5.5.6.9 Deployment
    • 5.5.6.10 Functionality
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Process
    • 5.6.1.9 Deployment
    • 5.6.1.10 Functionality
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Process
    • 5.6.2.9 Deployment
    • 5.6.2.10 Functionality
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Process
    • 5.6.3.9 Deployment
    • 5.6.3.10 Functionality
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Process
    • 5.6.4.9 Deployment
    • 5.6.4.10 Functionality
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Process
    • 5.6.5.9 Deployment
    • 5.6.5.10 Functionality

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Zebra Technologies
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Avery Dennison
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Impinj
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Alien Technology
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 NXP Semiconductors
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Checkpoint Systems
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Honeywell International
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Smartrac
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Invengo Technology
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 CAEN RFID
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Sato Holdings
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Identiv
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Tageos
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 RFID Global Solution
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 GAO RFID
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Omni-ID
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Confidex
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Mojix
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Vizinex RFID
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 ThingMagic
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us